A Phase 2 Randomised, Double-blind, Placebo Controlled Multicentre Study of Orally Administered ATL-104 to Assess Safety & Tolerance & Effect on Oral Mucositis in Patients with Haematological Malignancies After Treatment with Chemotherapy..

  • Mahendra, Premini (Principal Investigator)

Project Details

Short titleA Phase 2 Randomised, Double-blind, Placebo Controlled Multicentre Study of Orally Administered ATL-104 to Assess Safety & Tolerance & Effect on Oral Mucositis in Patients with Haematological Malignancies After Treatment with Chemotherapy..
StatusFinished
Effective start/end date28/07/04 → 27/06/06

Funding

  • Queen Elizabeth Hospital Birmingham